- Home
- ALVO vs QDEL Comparison
ALVO vs QDEL Comparison
Compare ALVO & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | QDEL |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 989.5M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ALVO | QDEL |
|---|---|---|
| Price | $5.85 | $10.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $8.00 | ★ $28.25 |
| AVG Volume (30 Days) | 972.6K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $13.28 | $3.51 |
| Revenue Next Year | $18.63 | $3.86 |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.94 | $9.92 |
| 52 Week High | $9.05 | $35.58 |
Technical Indicators
Market Signals| Indicator | ALVO | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 72.69 | 36.03 |
| Support Level | $3.10 | $9.92 |
| Resistance Level | N/A | $12.85 |
| Average True Range (ATR) | 0.26 | 0.64 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 81.47 | 14.56 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.